Open Access

Retraction Note: Ferroportin in the progression and prognosis of hepatocellular carcinoma

  • Qin Wang1,
  • Jun Zhou2Email author,
  • Dewu Zhong3,
  • Qunwei Wang2 and
  • Jiangsheng Huang2
European Journal of Medical Research201520:38

https://doi.org/10.1186/s40001-015-0132-6

Received: 25 January 2015

Accepted: 3 March 2015

Published: 26 March 2015

The original article was published in European Journal of Medical Research 2013 18:59

Retraction

The Publisher and Editor regretfully retract this article [1] because the peer-review process was inappropriately influenced and compromised. As a result, the scientific integrity of the article cannot be guaranteed. A systematic and detailed investigation suggests that a third party was involved in supplying fabricated details of potential peer reviewers for a large number of manuscripts submitted to different journals. In accordance with recommendations from COPE we have retracted all affected published articles, including this one. It was not possible to determine beyond doubt that the authors of this particular article were aware of any third party attempts to manipulate peer review of their manuscript.

Notes

Authors’ Affiliations

(1)
Department of Gynecology, The Second Xiangya Hospital of Central South University
(2)
Department of Minimal Invasive surgery, The Second Xiangya Hospital of Central South University
(3)
Department of General Surgery, The Second Xiangya Hospital of Central South UniversityChangsha

Reference

  1. Wang Q, Zhou J, Zhong D, Wang Q, Huang J. Ferroportin in the progression and prognosis of hepatocellular carcinoma. Eur J Med Res. 2013;18:59.View ArticlePubMed CentralPubMedGoogle Scholar

Copyright

© Wang et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement